Greetings and welcome to the Cubist Pharmaceuticals' Second Quarter 2010 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Eileen McIntyre, for Cubist Pharmaceuticals. Thank you, you may begin.
Ladies and gentlemen, thank you for standing by. We would like to welcome you to the Gilead Sciences First Quarter 2010 Earnings Conference Call. My name is Stacy and I will be your conference operator for today.